This content is restricted.
Brief
On 07/02/2025, the National Health Surveillance Agency (Anvisa) issued an update regarding CMED publishes consultation directed on pricing of advanced therapy products. The CTE/CMED invites professionals from the health sector, patients, representatives from the pharmaceutical industry, researchers, government entities, and others to participate in a public consultation to gather data and opinions on the criteria for pricing advanced therapy products.
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
